Analytics data have made it easier and faster to identify HCP prescribing trends, but understanding the specific factors driving these prescribing patterns (i.e., the root cause) often remains challenging.

For instance, when a company’s product is losing market share to a specific competitor among a specific HCP customer subset, there is a need to supplement analytics with a qualitative inquiry to achieve a detailed understanding of why this occurring.

Through 3rd-party agreements, prescriber-level IQVIA data allow us to recruit the specific HCPs that exhibit the prescribing trends of interest.

These studies can be one-time “spot” studies or they can be recurring HCP tracking studies.

The spot studies, intended to elucidate an emergent strategic problem, often demand a quick turnaround. From RFP to final deliverable, we can complete these HCP prescribing studies within 3-4 weeks, largely because we excel in our recruiting dedication and resourcefulness.

The HCP tracking studies provide brands team with ongoing and up-to-date strategic insight on HCPs’ perceptions and behaviors in the competitive landscape.

The tracking studies are typically composed of 3-4 annual “waves.” For each “wave” of the tracking study, there are a set of standard and recurring questions, but a new set of questions are also integrated that capture the team’s most immediate strategic interests.